Logo image of SOLB.BR

SOLVAY SA (SOLB.BR) Stock Fundamental Analysis

Europe - EBR:SOLB - BE0003470755 - Common Stock

27.46 EUR
-0.04 (-0.15%)
Last: 9/16/2025, 5:29:56 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to SOLB. SOLB was compared to 66 industry peers in the Chemicals industry. SOLB has a medium profitability rating, but doesn't score so well on its financial health evaluation. SOLB has a bad growth rate and is valued cheaply.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year SOLB was profitable.
In the past year SOLB had a positive cash flow from operations.
SOLB had positive earnings in 4 of the past 5 years.
Each year in the past 5 years SOLB had a positive operating cash flow.
SOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFSOLB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

SOLB's Return On Assets of 2.21% is fine compared to the rest of the industry. SOLB outperforms 62.12% of its industry peers.
With a decent Return On Equity value of 12.19%, SOLB is doing good in the industry, outperforming 77.27% of the companies in the same industry.
The Return On Invested Capital of SOLB (8.43%) is better than 74.24% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SOLB is above the industry average of 6.62%.
Industry RankSector Rank
ROA 2.21%
ROE 12.19%
ROIC 8.43%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
SOLB.BR Yearly ROA, ROE, ROICSOLB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

SOLB has a Profit Margin (2.81%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of SOLB has grown nicely.
SOLB has a Operating Margin of 10.64%. This is in the better half of the industry: SOLB outperforms 75.76% of its industry peers.
In the last couple of years the Operating Margin of SOLB has grown nicely.
The Gross Margin of SOLB (21.23%) is worse than 68.18% of its industry peers.
In the last couple of years the Gross Margin of SOLB has declined.
Industry RankSector Rank
OM 10.64%
PM (TTM) 2.81%
GM 21.23%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
SOLB.BR Yearly Profit, Operating, Gross MarginsSOLB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

SOLB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SOLB has less shares outstanding than it did 1 year ago.
The number of shares outstanding for SOLB has been increased compared to 5 years ago.
SOLB has a worse debt/assets ratio than last year.
SOLB.BR Yearly Shares OutstandingSOLB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
SOLB.BR Yearly Total Debt VS Total AssetsSOLB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

SOLB has an Altman-Z score of 1.87. This is not the best score and indicates that SOLB is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SOLB (1.87) is worse than 63.64% of its industry peers.
SOLB has a debt to FCF ratio of 9.16. This is a negative value and a sign of low solvency as SOLB would need 9.16 years to pay back of all of its debts.
SOLB has a Debt to FCF ratio of 9.16. This is in the better half of the industry: SOLB outperforms 63.64% of its industry peers.
SOLB has a Debt/Equity ratio of 1.80. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of SOLB (1.80) is worse than 89.39% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 9.16
Altman-Z 1.87
ROIC/WACC1.38
WACC6.11%
SOLB.BR Yearly LT Debt VS Equity VS FCFSOLB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

SOLB has a Current Ratio of 1.33. This is a normal value and indicates that SOLB is financially healthy and should not expect problems in meeting its short term obligations.
SOLB has a Current ratio of 1.33. This is in the lower half of the industry: SOLB underperforms 74.24% of its industry peers.
SOLB has a Quick Ratio of 1.33. This is a bad value and indicates that SOLB is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.96, SOLB is in line with its industry, outperforming 42.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.33
Quick Ratio 0.96
SOLB.BR Yearly Current Assets VS Current LiabilitesSOLB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2

3. Growth

3.1 Past

The earnings per share for SOLB have decreased strongly by -94.29% in the last year.
The Earnings Per Share has been growing by 153.72% on average over the past years. This is a very strong growth
SOLB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -57.61%.
SOLB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -14.50% yearly.
EPS 1Y (TTM)-94.29%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-11.54%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-7.71%

3.2 Future

The Earnings Per Share is expected to grow by 1.97% on average over the next years.
SOLB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.02% yearly.
EPS Next Y-18.61%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
EPS Next 5Y1.97%
Revenue Next Year-4.69%
Revenue Next 2Y-1%
Revenue Next 3Y0.33%
Revenue Next 5Y-0.02%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SOLB.BR Yearly Revenue VS EstimatesSOLB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 5B 10B 15B
SOLB.BR Yearly EPS VS EstimatesSOLB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15

8

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 7.21 indicates a rather cheap valuation of SOLB.
SOLB's Price/Earnings ratio is rather cheap when compared to the industry. SOLB is cheaper than 98.48% of the companies in the same industry.
When comparing the Price/Earnings ratio of SOLB to the average of the S&P500 Index (27.27), we can say SOLB is valued rather cheaply.
A Price/Forward Earnings ratio of 7.78 indicates a rather cheap valuation of SOLB.
98.48% of the companies in the same industry are more expensive than SOLB, based on the Price/Forward Earnings ratio.
SOLB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.77.
Industry RankSector Rank
PE 7.21
Fwd PE 7.78
SOLB.BR Price Earnings VS Forward Price EarningsSOLB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

87.88% of the companies in the same industry are more expensive than SOLB, based on the Enterprise Value to EBITDA ratio.
89.39% of the companies in the same industry are more expensive than SOLB, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.96
EV/EBITDA 5.47
SOLB.BR Per share dataSOLB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The decent profitability rating of SOLB may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.05
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%

5

5. Dividend

5.1 Amount

SOLB has a Yearly Dividend Yield of 6.19%, which is a nice return.
Compared to an average industry Dividend Yield of 3.04, SOLB pays a better dividend. On top of this SOLB pays more dividend than 95.45% of the companies listed in the same industry.
SOLB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 6.19%

5.2 History

The dividend of SOLB decreases each year by -9.94%.
Dividend Growth(5Y)-9.94%
Div Incr Years3
Div Non Decr Years4
SOLB.BR Yearly Dividends per shareSOLB.BR Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

SOLB pays out 182.73% of its income as dividend. This is not a sustainable payout ratio.
DP182.73%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
SOLB.BR Yearly Income VS Free CF VS DividendSOLB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B
SOLB.BR Dividend Payout.SOLB.BR Dividend Payout, showing the Payout Ratio.SOLB.BR Dividend Payout.PayoutRetained Earnings

SOLVAY SA

EBR:SOLB (9/16/2025, 5:29:56 PM)

27.46

-0.04 (-0.15%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)11-06 2025-11-06
Inst Owners26.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.91B
Analysts68.7
Price Target30.97 (12.78%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.19%
Yearly Dividend2.44
Dividend Growth(5Y)-9.94%
DP182.73%
Div Incr Years3
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.02%
Min EPS beat(2)9%
Max EPS beat(2)11.03%
EPS beat(4)3
Avg EPS beat(4)10.23%
Min EPS beat(4)-1.96%
Max EPS beat(4)22.86%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-3.62%
Min Revenue beat(2)-4.75%
Max Revenue beat(2)-2.48%
Revenue beat(4)0
Avg Revenue beat(4)-2.86%
Min Revenue beat(4)-4.75%
Max Revenue beat(4)-0.96%
Revenue beat(8)2
Avg Revenue beat(8)-1.68%
Revenue beat(12)6
Avg Revenue beat(12)4.24%
Revenue beat(16)10
Avg Revenue beat(16)9.1%
PT rev (1m)-3.9%
PT rev (3m)-7.89%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-19.05%
EPS NY rev (1m)-18.17%
EPS NY rev (3m)-18.17%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.81%
Revenue NY rev (3m)-5.91%
Valuation
Industry RankSector Rank
PE 7.21
Fwd PE 7.78
P/S 0.59
P/FCF 11.96
P/OCF 5.28
P/B 2.55
P/tB 17.73
EV/EBITDA 5.47
EPS(TTM)3.81
EY13.87%
EPS(NY)3.53
Fwd EY12.86%
FCF(TTM)2.3
FCFY8.36%
OCF(TTM)5.2
OCFY18.95%
SpS46.8
BVpS10.77
TBVpS1.55
PEG (NY)N/A
PEG (5Y)0.05
Profitability
Industry RankSector Rank
ROA 2.21%
ROE 12.19%
ROCE 11.24%
ROIC 8.43%
ROICexc 9.07%
ROICexgc 11.69%
OM 10.64%
PM (TTM) 2.81%
GM 21.23%
FCFM 4.9%
ROA(3y)13.55%
ROA(5y)7.71%
ROE(3y)64.09%
ROE(5y)37.45%
ROIC(3y)11.19%
ROIC(5y)8.96%
ROICexc(3y)12.43%
ROICexc(5y)9.87%
ROICexgc(3y)17.2%
ROICexgc(5y)14.4%
ROCE(3y)14.91%
ROCE(5y)11.94%
ROICexcg growth 3Y8.77%
ROICexcg growth 5Y9.63%
ROICexc growth 3Y18.23%
ROICexc growth 5Y16.44%
OM growth 3Y5%
OM growth 5Y4.03%
PM growth 3Y-17.12%
PM growth 5Y176.86%
GM growth 3Y-4.43%
GM growth 5Y-3.41%
F-Score4
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 1.8
Debt/FCF 9.16
Debt/EBITDA 2.33
Cap/Depr 87.75%
Cap/Sales 6.22%
Interest Coverage 7.75
Cash Conversion 62.76%
Profit Quality 174.82%
Current Ratio 1.33
Quick Ratio 0.96
Altman-Z 1.87
F-Score4
WACC6.11%
ROIC/WACC1.38
Cap/Depr(3y)94.75%
Cap/Depr(5y)76.26%
Cap/Sales(3y)9.62%
Cap/Sales(5y)7.99%
Profit Quality(3y)83.5%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-94.29%
EPS 3Y-37%
EPS 5Y153.72%
EPS Q2Q%-11.54%
EPS Next Y-18.61%
EPS Next 2Y-7.07%
EPS Next 3Y-0.64%
EPS Next 5Y1.97%
Revenue 1Y (TTM)-57.61%
Revenue growth 3Y-23.45%
Revenue growth 5Y-14.5%
Sales Q2Q%-7.71%
Revenue Next Year-4.69%
Revenue Next 2Y-1%
Revenue Next 3Y0.33%
Revenue Next 5Y-0.02%
EBIT growth 1Y-67.31%
EBIT growth 3Y-19.61%
EBIT growth 5Y-11.06%
EBIT Next Year39.83%
EBIT Next 3Y15.32%
EBIT Next 5Y8.97%
FCF growth 1Y-79.37%
FCF growth 3Y-27.42%
FCF growth 5Y-19.2%
OCF growth 1Y-75.53%
OCF growth 3Y-25.69%
OCF growth 5Y-19.46%